Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
30
Number of overlapping holdings
60.0%
% of FTXH's 51 holdings also in XBI
23.3%
% of XBI's 129 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
UNITED THERAPEUTICS CORP | 4.9% | 3.2% | 3.2% |
|
GILEAD SCIENCES INC | 3.7% | 3.0% | 3.0% |
|
ABBVIE INC | 7.4% | 2.9% | 2.9% |
|
REGENERON PHARMACEUTICALS | 4.1% | 2.9% | 2.9% |
|
AMGEN INC | 4.1% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XBI
|
PFIZER INC | 7.3% |
|
JOHNSON & JOHNSON | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 6.6% |
|
MERCK & CO. INC. | 6.2% |
|
ABBVIE INC | 4.5% |
|
ELI LILLY & CO | 4.3% |
|
CARDINAL HEALTH INC | 3.4% |
|
VIATRIS, INC. | 3.3% |
|
ZOETIS INC | 3.1% |
|
ORGANON & CO. | 2.9% |
FTXH Underweight Relative to XBI
|
EXACT SCIENCES CORP | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -2.9% |
|
NATERA INC | -2.6% |
|
VIKING THERAPEUTICS, INC. | -2.5% |
|
BIOMARIN PHARMACEUTICAL INC | -2.2% |
|
SAREPTA THERAPEUTICS INC | -2.2% |
|
CYTOKINETICS INC | -2.0% |
|
INCYTE CORP | -1.5% |
|
MODERNA, INC. | -1.4% |
|
NEUROCRINE BIOSCIENCES INC | -1.3% |